z-logo
open-access-imgOpen Access
FDA issues warning letters to two breast implant manufacturers for failure to comply with post-approval study requirements
Publication year - 2019
Publication title -
case medical research
Language(s) - English
Resource type - Journals
ISSN - 2643-4652
DOI - 10.31525/fda2-ucm633890.htm
Subject(s) - medicine , breast implant , business , risk analysis (engineering) , medical physics , implant , surgery

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom